Genetic Technologies Stock Price on November 25, 2024
| GENE Stock | USD 0.77 0.00 0.00% |
Below is the normalized historical share price chart for Genetic Technologies extending back to September 02, 2005. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Genetic Technologies stands at 0.77, as last reported on the 25th of November, with the highest price reaching 0.77 and the lowest price hitting 0.77 during the day.
If you're considering investing in Genetic Stock, it is important to understand the factors that can impact its price. Genetic Technologies holds Efficiency (Sharpe) Ratio of -0.16, which attests that the entity had a -0.16% return per unit of risk over the last 3 months. Genetic Technologies exposes nineteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Genetic Technologies' Risk Adjusted Performance of (0.09), market risk adjusted performance of (6.22), and Standard Deviation of 1.74 to validate the risk estimate we provide.
At present, Genetic Technologies' Capital Stock is projected to increase significantly based on the last few years of reporting. . As of November 25, 2024, Price To Sales Ratio is expected to decline to 1.33. In addition to that, Price Earnings Ratio is expected to decline to -0.94. Genetic Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 2nd of September 2005 | 200 Day MA 1.5476 | 50 Day MA 0.7696 | Beta 0.48 |
Genetic |
Sharpe Ratio = -0.1637
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | GENE |
Estimated Market Risk
| 1.71 actual daily | 15 85% of assets are more volatile |
Expected Return
| -0.28 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.16 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Genetic Technologies is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Genetic Technologies by adding Genetic Technologies to a well-diversified portfolio.
Price Book 3.1122 | Enterprise Value Ebitda (2.44) | Price Sales 0.3834 | Shares Float 27.9 M | Wall Street Target Price 12.5 |
Genetic Technologies Valuation on November 25, 2024
It is possible to determine the worth of Genetic Technologies on a given historical date. On November 25, 2024 Genetic was worth 0.77 at the beginning of the trading date compared to the closed value of 0.77. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Genetic Technologies stock. Still, in general, we apply an absolute valuation method to find Genetic Technologies' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Genetic Technologies where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Genetic Technologies' related companies.
| Open | High | Low | Close | Volume | |
| 0.77 | 0.77 | 0.77 | 0.77 | 1.00 | |
11/25/2024 | 0.77 | 0.77 | 0.77 | 0.77 | 0.00 |
| Backtest Genetic Technologies | | | Genetic Technologies History | | | Genetic Technologies Valuation | Previous |
Genetic Technologies Trading Date Momentum on November 25, 2024
| On November 25 2024 Genetic Technologies was traded for 0.77 at the closing time. The top price for the day was 0.77 and the lowest listed price was 0.77 . There was no trading activity during the period 0.0. Lack of trading volume on November 25, 2024 did not cause price change. The overall trading delta against the current closing price is 0.00% . |
Genetic Technologies Fundamentals Correlations and Trends
By evaluating Genetic Technologies' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Genetic Technologies' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Genetic financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Genetic Technologies Stock history
Genetic Technologies investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Genetic is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Genetic Technologies will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Genetic Technologies stock prices may prove useful in developing a viable investing in Genetic Technologies
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 132.2 M | 138.8 M | |
| Net Loss | -10.6 M | -11.1 M |
Genetic Technologies Stock Technical Analysis
Genetic Technologies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Genetic Technologies Period Price Range
Low | November 25, 2024
| High |
0.00 | 0.00 |
Genetic Technologies cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Genetic Technologies November 25, 2024 Market Strength
Market strength indicators help investors to evaluate how Genetic Technologies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Genetic Technologies shares will generate the highest return on investment. By undertsting and applying Genetic Technologies stock market strength indicators, traders can identify Genetic Technologies entry and exit signals to maximize returns
Genetic Technologies Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Genetic Technologies' price direction in advance. Along with the technical and fundamental analysis of Genetic Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Genetic to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.24) | |||
| Total Risk Alpha | (0.51) | |||
| Treynor Ratio | (6.23) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Genetic Stock analysis
When running Genetic Technologies' price analysis, check to measure Genetic Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genetic Technologies is operating at the current time. Most of Genetic Technologies' value examination focuses on studying past and present price action to predict the probability of Genetic Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genetic Technologies' price. Additionally, you may evaluate how the addition of Genetic Technologies to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |